Treatment

Approval of aducanumab for Alzheimer’s disease

The potential druggability of OAS1 leading to new AD and COVID-19 treatments

Identifying innate immune system genes linked to AD

Identifying a new link between TREM2 and IL-4 signaling in microglia

The Cognition and Flow Study: the effects of brain training on brain blood flow

Medical management issues in dementia: recommendations

EAN guidance on managing patients with dementia

Therapeutic development in Alzheimer’s disease and the lack of funding

Identifying new therapeutic targets for neurodegenerative diseases

The future of Alzheimer’s disease: aducanumab

Hopeful developments for Alzheimer’s Disease

CT1812: exciting preliminary results

Therapeutics designed to mimic protective mutations for Alzheimer’s disease

The use of digital memory notebooks to improve memory impairment

Repurposing existing drugs to treat Alzheimer’s disease

The importance of early treatment and diagnosis of Alzheimer’s disease